Erasca (ERAS) Net Income Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | -492.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -492.46% |
| Dec 31, 2025 | 4.57% |
| Sep 30, 2025 | 2.54% |
| Jun 30, 2025 | 46.40% |
| Mar 31, 2025 | 11.57% |
| Dec 31, 2024 | -2.45% |
| Sep 30, 2024 | -3.33% |
| Jun 30, 2024 | -98.86% |
| Mar 31, 2024 | -5.48% |
| Dec 31, 2023 | 78.04% |
| Sep 30, 2023 | 14.45% |
| Jun 30, 2023 | 10.75% |
| Mar 31, 2023 | 8.94% |
| Dec 31, 2022 | -336.74% |
| Sep 30, 2022 | 22.97% |
| Jun 30, 2022 | -26.21% |
| Mar 31, 2022 | -85.71% |
| Dec 31, 2021 | 53.73% |
| Sep 30, 2021 | -312.69% |
| Jun 30, 2021 | -289.32% |